Mayo Clinic researchers today presented results of a phase II trial of myeloma induction therapy -- a first step therapy designed to reduce cancer cells numbers -- with cyclophosphamide, bortezomib, ...
Mayo Clinic researchers have presented results of a phase II trial of myeloma induction therapy -- a first step therapy designed to reduce cancer cells numbers -- with cyclophosphamide, bortezomib, ...
In vitro antimyeloma activity of the iron chelator deferasirox (DFX).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results